Skip to content
healthcare.dev

PHENTERMINE HYDROCHLORIDE

NDC 13107-061, PHENTERMINE HYDROCHLORIDE, tablet, from Aurolife Pharma LLC.

Product NDC
13107-061
Status
Listed
Labeler
Aurolife Pharma LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA203068
DEA schedule
CIV
Request
curl https://api.healthcare.dev/v1/drugs/ndc/13107-061 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PHENTERMINE HYDROCHLORIDE37.5 mg/1

Pharmacologic classes

Appetite Suppression [PE]; Increased Sympathetic Activity [PE]; Sympathomimetic Amine Anorectic [EPC]

Package NDCNDC-11Package
13107-061-0113107006101100 TABLET in 1 BOTTLE (13107-061-01)
13107-061-301310700613030 TABLET in 1 BOTTLE (13107-061-30)
13107-061-99131070061991000 TABLET in 1 BOTTLE (13107-061-99)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/5927e0f6-3de3-4885-a633-5b92003f6fe4

Use it

Look up 13107-061 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/13107-061 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 13107-061. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.